Search

everythinglearnresearchcommunity

for

Search:↓

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Minoxidil-loaded NLC gel shows potential for effective alopecia treatment.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Oxidative stress affects hair loss in men with androgenetic alopecia.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

A girl with rickets and hair loss was found to have a rare condition where her body didn't respond to vitamin D treatment.

Four genetic risk spots found for hair loss, with WNT signaling involved and a link to curly hair.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

Minoxidil helps hair growth and reduces shedding in women.

Vitamin D receptor is crucial for starting hair growth after birth.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

New genes found linked to balding, may help develop future treatments.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Finasteride improves acne and hair loss in women with normal testosterone.

No systemic treatment for alopecia areata has strong evidence of effectiveness.